The FDA said it's looking into the risk of severe hypocalcemia among patients on dialysis receiving denosumab (Prolia), citing the potential for severe outcomes, including hospitalization and death.
Medically reviewed by Sameena Zahoor, MD Key Takeaways Reactive hypoglycemia is low blood sugar happening within four hours of eating.Symptoms of reactive hypoglycemia include a fast heartbeat, ...